M3D, INC.

ANN ARBOR, MI · Founded 2021 · Medtech · Private

A real-time 3D gamma-ray imaging system for surgical guidance during cancer lymph node biopsy and resection procedures

Claim this profile

Follows are private to you and power your alerts

Updated · m3d.com

Sector
Medtech
Headquarters
ANN ARBOR, MI
Founded
2021
Latest Form D
$250K, Nov 2023
Total capital
$525K
Federal grants
$275K
1 award · 2024
Rank in peer group#150 of 445
Private capital raised
$250K
1 Form D · last Nov 2023
35 months since last filing
Federal contracts
None on recordNo federal contract awards found.
Granted patents
0
6 pending

Capital timeline

20232024FEDERAL ↑EQUITY ↓Cumulative $525K$275K1st Form D$250K
20232024FEDERAL ↑EQUITY ↓Cumulative $525K$275K1st Form D$250K

Latest events

  • Federal grantNSF · Phase I · SBIR Phase I: Gamma Camera Design Studies for Intraoperative Imaging$275K
  • Private capital raisedForm D · SEC · 1st filing$250K

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Standing among 445 peers

Line = median

Medtech · Device

  • Federal grants#150 · top 34%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

From SEC Form D filings
  • Michael HopkinsExecutive Officer, DirectorNamed in SEC Form D filings

What it has protected

USPTO · 0 granted of 6
  • PendingLocal Radiation Imaging Via Three-dimensional (3D) Cadmium-zinc-telluride (czt) Systems With Aperture MasksUSPTOApplication 18891478
  • PendingThree-dimensional (3D) Cadmium-zinc-telluride (czt) Detector System For Extended Reality Intrasurgical GuidanceUSPTOApplication PCTUS2025029392
  • PendingLocal Radiation Imaging Via Three-dimensional (3D) Cadmium-zinc-telluride (czt) Systems With Aperture MasksUSPTOApplication PCTUS2024047647
Show all 6 patent records
  • Local Radiation Imaging Via Three-dimensional (3D) Cadmium-zinc-telluride (czt) Systems With Aperture MasksMar 20, 2025 · Application 18891478Pending
  • Three-dimensional (3D) Cadmium-zinc-telluride (czt) Detector System For Extended Reality Intrasurgical GuidanceApplication PCTUS2025029392Pending
  • Local Radiation Imaging Via Three-dimensional (3D) Cadmium-zinc-telluride (czt) Systems With Aperture MasksApplication PCTUS2024047647Pending
  • Three-dimensional (3D) Cadmium-zinc-telluride (czt) Detector System For Extended Reality Intrasurgical GuidanceApplication 63647815Pending
  • Three-dimensional (3D) Cadmium-zinc-telluride (czt) Radiation DetectionApplication 63583909Pending
  • Techniques For Enhancing Intra-operative Three-dimensional (3D) Radiotracer Detection In Sentinel Lymph NodesApplication 63583957Pending

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .